Floatz logo

Sonlicromanol

Chronic Progressive External Ophthalmoplegia (CPEO)

Khondrion BVSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Chronic Progressive External Ophthalmoplegia (CPEO) cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Sonlicromanol is also rated in:

mitochondrial diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Mitochondrial DNA tRNALeu(UUR) m.3243A<G MutationDormant
BB
Indicative ·
70 / 100
View asset →
MELAS syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →